Silexion Therapeutics Warrant
SLXNW
25 hedge funds and large institutions have $199K invested in Silexion Therapeutics Warrant in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 4 closing their positions.
117% more capital invested
Capital invested by funds: $91.7K → $199K (+$107K)
0.27% more ownership
Funds ownership: 23.55% → 23.82% (+0.27%)
4% less funds holding
Funds holding: 26 → 25 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.15K |
| 2 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
+$2.32K |
| 3 |
GF
Gabelli Funds
Rye,
New York
|
+$1.86K |
| 4 |
Goldman Sachs
New York
|
+$159 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Trading
New York
|
-$1.19K |
| 2 |
GS
GTS Securities
New York
|
-$799 |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$456 |
| 4 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$343 |
| 5 |
HP
Hartree Partners
New York
|
-$313 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Walleye Trading
New York
| – | -$1.19K | -35,000 | Closed |
|
|
GS
27
GTS Securities
New York
| – | -$799 | -23,498 | Closed |
|
|
28
Citadel Advisors
Miami,
Florida
| – | -$456 | -13,580 | Closed |
|
|
WAM
29
Wolverine Asset Management
Chicago,
Illinois
| – | -$296 | -8,735 | Closed |
|
SLXNW Hedge Fund Activity: Q1 2025 in Review
25 of the 7,462 institutional investors tracked by Wall St. Rank reported a position in Silexion Therapeutics Warrant (SLXNW) for Q1 2025, worth a combined $199K — up 117% from $91.7K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SLXNW and 3 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $3.15K. The largest seller was Walleye Trading, exiting entirely with an estimated $1.19K sold.
- 25 institutional investors held Silexion Therapeutics Warrant (SLXNW) as of Q1 2025, down from 26 in Q4 2024.
- Funds reported $199K of Silexion Therapeutics Warrant stock for Q1 2025, up 117% quarter-over-quarter.
- 3 funds opened new Silexion Therapeutics Warrant positions in Q1 2025 and 4 closed out, a net change of -1 holder.
- The largest Silexion Therapeutics Warrant buyer in Q1 2025 was Susquehanna International Group, an estimated $3.15K added.
- The largest Silexion Therapeutics Warrant seller in Q1 2025 was Walleye Trading, an estimated $1.19K sold.
Based on aggregated 13F filings for Q1 2025.